The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2028

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

Ablation Procedure

Ablation Procedure for paroxysmal atrial fibrillation

Trial Locations (21)

15212

RECRUITING

Allegheny Health, Pittsburgh

19104

RECRUITING

University of Pennsylvania (UPENN), Philadelphia

22601

RECRUITING

Valley Health System, Winchester

23226

RECRUITING

Bon Secours Medical Group - Richmond Specialty Care, Richmond

24501

RECRUITING

Centra Health, Inc.dba Stroobants Cardiovascular Center, Lynchburg

30309

RECRUITING

Piedmont Healthcare, Atlanta

34102

WITHDRAWN

Naples Community Hospital, Naples

34239

RECRUITING

Sarasota Memorial Health, Sarasota

35209

RECRUITING

Arrhythmia Institute at Grandview, Birmingham

36608

RECRUITING

Mobile Cardiology Associates, Mobile

40205

RECRUITING

Norton Heart and Vascular Institute, Louisville

45219

RECRUITING

The Christ Hospital, Cincinnati

45221

RECRUITING

University of Cincinnati, Cincinnati

48197

RECRUITING

Trinity Health-Michigan Heart, Ypsilanti

48912

RECRUITING

Sparrow Clinical Research Institute, Lansing

53548

RECRUITING

Mercy Health, Janesville

80012

RECRUITING

Medical City - HCA, Aurora

93003

RECRUITING

Community Memorial Health System, Ventura

98372

RECRUITING

Multicare Health Systems-Pulse Heart, Puyallup

98401

RECRUITING

Franciscan Heart and Vascular Associates, Tacoma

02115

NOT_YET_RECRUITING

The Brigham and Womens Hospital, Boston

All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Heart Rhythm Clinical and Research Solutions, LLC

OTHER